Science Current Events | Science News | Brightsurf.com
 

Emission Reduction Current Events | Emission Reduction News | 11
Page 11 of 22 | 541 Results
Previous0607080910111213141516   Next   
Sort By: Page Views | Date
Amias® (candesartan cilexetil), an antihypertensive drug, now shows clear benefits in symptomatic heart failure
Amias® (candesartan cilexetil), an antihypertensive drug, now shows clear benefits in symptomatic heart failure CHARM Study Programme demonstrates that Amias® saves lives and reduces hospitalisation in heart failure, irrespective of background therapy European Society of Cardiology, Vienna,... view more (2003-08-31)

Magnetism shapes beauty in the heavens
Using a technique based on the work of the 1902 Nobel Prizewinner, Pieter Zeeman, an international team of astronomers have, for the first time, provided conclusive proof that the magnetic field close to a number of aging stars is 10 to 100 times stronger than that of our own Sun. These... view more (2002-11-01)

Medicare modernization act did not change chemotherapy as feared
Cancer patients receiving chemotherapy have not noticed a restriction in their access to treatment following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in government reimbursement to oncologists,... view more (2007-10-08)

Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the... view more (2008-04-30)

Cocoa, but not tea, may lower blood pressure
Foods rich in cocoa appear to reduce blood pressure but drinking tea may not, according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.   view more (2007-04-10)

Cure for cancer worth $50 trillion
A new study, to be published in a forthcoming issue of the Journal of Political Economy, calculates the prospective gains that could be obtained from further progress against major diseases.   view more (2006-04-27)

The accretion disks around super-massive black holes: do they really exist?
Active Galactic Nuclei (AGN) and quasars (QSO) are the most luminous objects in the sky. These are powered by accretion of interstellar gas onto a supermassive black hole (BH) of about 100 millions solar masses which stands at the center of galaxies. For Seyfert galaxies, a few tenths of solar... view more (2001-04-17)

New Herceptin results confirm impressive reduction in risk of cancer returning
New Herceptin results confirm impressive reduction in risk of cancer returning in women with aggressive form of early-stage breast cancer.   view more (2005-09-14)

Arthritis self-management does not reduce pain levels or GP visits
Self-management programmes for people with osteoarthritis do not reduce pain, or the number of visits patients make to their GP, a new study reveals today.   view more (2006-10-16)

Chemical Industry Gives Mixed Response to Greenhouse Gas Emissions Trading Scheme
The Chemical Industries Association (CIA) today expressed concern that the UK's allocation of greenhouse gas emissions is still not finally decided, but applauded the UK Government's decision to press the European Commission for approval of the revised limits.   view more (2005-02-15)

Vaccine May Complement Conventional Treatment For Chronic Leukaemia
A vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia (CML), suggest early results of a trial published in this week's issue of The Lancet.   view more (2005-02-16)

Multi-wavelength images help astronomers study star birth, death
In recent years, a number of ground-based optical and radio surveys of the Large and Small Magellanic Clouds - Earth's nearest neighboring galaxies - have become available.   view more (2006-01-12)

Emergency bypass surgery on angioplasty patients drops 90 percent
When life-threatening problems occur during angioplasty procedures, doctors may perform emergency coronary artery bypass graft surgery, but data from the Mayo Clinic indicates that need to send patients to emergency surgery has dropped sharply.   view more (2005-11-30)

Silver is the key to reducing pneumonia associated with breathing tubes
People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving critically ill patients another reason to value the lustrous metal.   view more (2008-08-20)

New trial sparks debate over treatment of diabetic hypertensives
A major new international study published in the Journal of Hypertension (July 21 2004) has challenged traditional thinking by revealing that the thiazide-like diuretic indapamide SR (Natrilix SR) has equivalent efficacy to enalapril in reducing microalbuminuria (MA) in patients with type 2... view more (2004-07-21)

Research into soy will continue but soy is not a solution for heart disease
Many soy food products carry health claims stating that they reduce the risk of heart disease. A review of the evidence, however, suggests that soy's cardiovascular benefits may have been overestimated by the early studies that formed the basis for its health claim.   view more (2006-02-07)

Cognitive Behaviour Therapy Is At Least As Good As Antidepressant Drugs In Generalized Anxiety Disorder
Chronic, constant worry (Generalized Anxiety Disorder) is most frequently treated with psychotropic drugs (benzodiazepines and antidepressants). A randomized controlled trial published in the Jan 2005 issue of Psychotherapy and Psychosomatics by a group of researchers of the University of Berlin... view more (2005-01-17)

University of Leicester is Hub in Network of Excellence for Cancer Research
In a considerable coup for the University of Leicester, the EU has awarded Professor Peter Farmer, of the Departments of Biochemistry and Cancer Studies and Molecular Medicine, a prestigious grant to participate in the establishment of a Europe-wide Network of Excellence.   view more (2005-05-10)

Researchers find specific statin significantly reduces Alzheimer's and Parkinson's disease risk
Researchers from Boston University School of Medicine (BUSM) have found that the statin, simvastatin, reduces the incidence of Alzheimer's disease and Parkinson's disease by almost 50 percent.   view more (2007-07-19)

New Treatment for Radiotherapy-Induced Side Effects Developed at Oxford
As seen in recent health news reports, treatments for side effects associated with radiotherapy are in high demand. An Oxford University scientist at the Research Institute of Oxford’s Churchill Hospital has invented a new non-toxic compound therapy that has shown positive results in the... view more (2002-10-09)

Community-based measures fail to reduce HIV levels, new study shows
Interventions that target individuals with a high risk of contracting HIV have a negligible impact on HIV transmission in the general population, according to a new study of communities in Zimbabwe, published today.   view more (2007-03-27)

UK researchers announce continuous Terahertz emission innovation
Researchers at the University of Leeds' Institute of Microwaves and Photonics have developed a novel way of generating continuous tunable Terahertz (THz) radiation.   view more (2002-11-14)

Preventing obesity in children — research highlights physical activity levels
A British study, involving 5,500 children and published in the latest issue of PLoS Medicine, used accurate methods to measure the 'fat mass' of the children and the amount of physical activity they were taking.   view more (2007-03-20)

Clock-shifts affect risk of heart attack
Adjusting the clocks to summer time on the last Sunday in March increases the risk of myocardial infarction in the following week. In return, putting the clocks back in the autumn reduces the risk, albeit to a lesser extent.   view more (2008-10-31)

INEGY™ (Ezetimibe/Simvastatin) Receives First Approval in Europe
Merck & Co., Inc. and Schering-Plough Corporation today announced the regulatory approval of INEGY™ in Germany. INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or 'bad' cholesterol) through Dual Inhibition of both cholesterol production in the liver and... view more (2004-04-02)
Page 11 of 22 | 541 Results
Previous0607080910111213141516   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com